tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Compare Crinetics Pharmaceuticals (CRNX) vs. Competitors

766 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Crinetics Pharmaceuticals
$39.44
$4.13B
-8.91
46.89%
8 Buy
0 Hold
0 Sell
Strong Buy
Ligand Pharma
$204.92
$4.09B
29.38
102.31%
7 Buy
0 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$23.30
$2.25B
-3.94
-29.73%
17 Buy
2 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$40.79
$5.21B
117.08%
3 Buy
16 Hold
0 Sell
Hold
Kymera Therapeutics
$85.05
$6.94B
-18.86
279.69%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRNX
Crinetics Pharmaceuticals
39.44
9.66
32.44%
LGND
Ligand Pharma
204.92
98.33
92.25%
RARE
Ultragenyx Pharmaceutical
23.30
-11.62
-33.28%
APLS
Apellis Pharmaceuticals
40.79
21.46
111.02%
AKRO
KYMR
Kymera Therapeutics
85.05
59.62
234.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts